Search results
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss
The Wall Street Journal· 7 days agoMeanwhile, sales of Vyvanse fell 11% to Y110.3 billion after Takeda lost U.S. market exclusivity for...
Marines Suffer Most Cases of 2 Life-Threatening Conditions Related to Exercise and Heat, Report...
Military.com via Yahoo News· 1 day agoThe April issue of the Defense Department's Medical Surveillance Monthly Report, published last...
HC Wainwright Trims Mind Medicine (MindMed) (NASDAQ:MNMD) Target Price to $35.00
ETF DAILY NEWS· 3 days agoMind Medicine (MindMed) (NASDAQ:MNMD – Free Report) had its price objective reduced by HC Wainwright from $75.00 to $35.00 in a research note released on Friday morning, Benzinga reports. They ...
Cingulate Inc. (NASDAQ:CING) Short Interest Down 65.5% in April
ETF DAILY NEWS· 3 days agoCingulate Inc. (NASDAQ:CING – Get Free Report) saw a significant drop in short interest during the month of April. As of April 30th, there was short interest totalling 4,800 shares, a drop of ...
Myla's Mission 5K/UTV ride is May 18
Greensburg Daily News, Ind. via Yahoo News· 20 hours agoMay 14—GREENSBURG — The seventh annual Myla's Mission for Sturge-Weber Research and Awareness 5K and UTV/Jeep ride is scheduled for Saturday, May 18, at Lake Santee's main beach. Over the past ...
New research reveals urgent need for integrated care in pediatric epilepsy
Medical Xpress· 2 days agoFindings from the Kennedy Krieger Institute emphasize the critical importance of integrated care for...
Managing Comorbidities in Chronic Urticaria
MedPage Today· 7 days agoThe link between chronic urticaria and atopic diseases, autoimmune diseases, and psychiatric disorders has significant implications for clinical practice. Managing comorbidities ...
Mother sentenced for injuring child
Martinsville Bulletin· 6 days agoIn addition to a charge of malicious wounding, Shantel Marie Hairston, 29, of Martinsville, was charged on March 24, 2022, with endangering the life of...
Aquestive Therapeutics (NASDAQ:AQST) Earns “Buy” Rating from HC Wainwright
ETF DAILY NEWS· 4 days agoHC Wainwright reiterated their buy rating on shares of Aquestive Therapeutics (NASDAQ:AQST – Free Report) in a report published on Thursday, Benzinga reports. HC Wainwright currently has a $9.00 ...
Breaking New Ground in Behavioral Science: The Rise of AI-Driven Analysis Tools
USA Today· 6 days agoFittingly, there’s a fast-developing family of AI-driven analytical tools that behavioral science is...